These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
111 related articles for article (PubMed ID: 3963919)
1. Hemodynamic, metabolic, and morphological effects of cardiopulmonary bypass with a fluorocarbon priming solution. Stone JJ; Piccione W; Berrizbeitia LD; Dance GR; Schoen FJ; Shemin RJ; Cohn LH Ann Thorac Surg; 1986 Apr; 41(4):419-24. PubMed ID: 3963919 [TBL] [Abstract][Full Text] [Related]
2. Fluosol-DA: an artificial blood for total cardiopulmonary bypass. Engelman RM; Rousou JH; Dobbs WA Ann Thorac Surg; 1981 Dec; 32(6):528-35. PubMed ID: 7316587 [TBL] [Abstract][Full Text] [Related]
3. Hemodilution and myocardial oxygen supply. The influence of fluosol-DA. Vogel H; Günther H; Harrison DK; Anderer W; Kessler M; Peter K Adv Exp Med Biol; 1989; 248():653-61. PubMed ID: 2782181 [No Abstract] [Full Text] [Related]
4. Effects of intracoronary infusion of arterial blood or Fluosol-DA 20% on regional myocardial metabolism and function during brief coronary artery occlusions. Tokioka H; Miyazaki A; Fung P; Rajagopalan RE; Kar S; Meerbaum S; Corday E; Drury JK Circulation; 1987 Feb; 75(2):473-81. PubMed ID: 2948736 [TBL] [Abstract][Full Text] [Related]
5. Effects of fluorocarbons with and without oxygen supplementation on cardiac hemodynamics and energetics. Rude RE; Bush LR; Tilton GD Am J Cardiol; 1984 Oct; 54(7):880-3. PubMed ID: 6207721 [TBL] [Abstract][Full Text] [Related]
6. Cardioplegic protection with hypothermic K-Fluosol DA and K/Mg-Fluosol DA solutions. Kyösola K; Harjula A; Mattila S; Aalto-Setälä K; Mattila I; Mattila P; Salmenperä M; Merikallio E Scand J Thorac Cardiovasc Surg; 1985; 19(3):267-72. PubMed ID: 4081676 [TBL] [Abstract][Full Text] [Related]
7. Metabolic and hemodynamic effects of hypertonic solutions: sodium-lactate versus sodium chloride infusion in postoperative patients. Mustafa I; Leverve XM Shock; 2002 Oct; 18(4):306-10. PubMed ID: 12392272 [TBL] [Abstract][Full Text] [Related]
8. Short term survival following perfusion with fluosol-DA for cardiopulmonary bypass. Rousou JA; Engelman RM; Breyer RH; Allred C; Forouhar F Int J Artif Organs; 1985 Sep; 8(5):281-6. PubMed ID: 3936789 [TBL] [Abstract][Full Text] [Related]
9. Effects of different oxygen concentrations during hemodilution with Fluosol or LMW-Dextran in rabbits. Beisbarth H; Madjidi A; Frey R Prog Clin Biol Res; 1983; 122():373-80. PubMed ID: 6192450 [No Abstract] [Full Text] [Related]
10. Beneficial effect of fluorocarbon reperfusion on postoperative cardiac dysfunction of transplanted heart. Ueda K; Genda T; Hirata I; Shimada M; Shibata T; Ueda T; Omoto R J Heart Lung Transplant; 1992; 11(4 Pt 1):646-55. PubMed ID: 1498127 [TBL] [Abstract][Full Text] [Related]
11. Limitation of myocardial reperfusion injury by intravenous perfluorochemicals. Role of neutrophil activation. Bajaj AK; Cobb MA; Virmani R; Gay JC; Light RT; Forman MB Circulation; 1989 Mar; 79(3):645-56. PubMed ID: 2537160 [TBL] [Abstract][Full Text] [Related]